Intelligent Bio Solutions (INBS) Change in Receivables (2021 - 2025)
Intelligent Bio Solutions' quarterly Change in Receivables came in at $244883.0 in Q1 2025, up 152.28% year-on-year from $97067.0 in Q1 2024, and up 178.36% quarter-over-quarter from -$312498.0 in Q4 2024.
Intelligent Bio Solutions has reported Change in Receivables for 5 years, with the latest figure at $244883.0 in Q1 2025.
- For the quarter ending Q1 2025, Change in Receivables rose 152.28% year-over-year to $244883.0; the trailing twelve-month figure through Mar 2025 stood at $178326.0 (up 179.28% YoY), and the FY2023 full-year result was $293861.0, up 116.07% from the prior year.
- Change in Receivables for Q1 2025 stood at $244883.0, up from -$312498.0 in the prior quarter.
- The five-year high for Change in Receivables was $674984.0 in Q4 2021, with the low at -$2.5 million in Q3 2021.
- Average Change in Receivables over 5 years is -$115644.2, with a median of $47439.5 recorded in 2023.
- Year-over-year, Change in Receivables plunged 167.92% in 2023 and surged 1971.71% in 2024.
- Tracing INBS's Change in Receivables over 5 years: stood at $674984.0 in 2021, then slumped by 33.54% to $448567.0 in 2022, then slumped by 167.92% to -$304676.0 in 2023, then fell by 2.57% to -$312498.0 in 2024, then surged by 178.36% to $244883.0 in 2025.
- The last three Change in Receivables figures came in at $244883.0 (Q1 2025), -$312498.0 (Q4 2024), and $148874.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 244,883.00 |
| Mar 31, 2025 | 244,883.00 |
| Dec 31, 2024 | -312,498.00 |
| Dec 31, 2024 | -312,498.00 |
| Sep 30, 2024 | 148,874.00 |
| Sep 30, 2024 | 148,874.00 |
| Mar 31, 2024 | 97,067.00 |
| Mar 31, 2024 | 97,067.00 |
| Dec 31, 2023 | -304,676.00 |
| Dec 31, 2023 | -304,676.00 |
| Sep 30, 2023 | 273,649.00 |
| Sep 30, 2023 | 273,649.00 |
| Jun 30, 2023 | -2,188.00 |
| Jun 30, 2023 | -2,188.00 |
| Mar 31, 2023 | -5,186.00 |
| Mar 31, 2023 | -5,186.00 |
| Dec 31, 2022 | 448,567.00 |
| Dec 31, 2022 | 448,567.00 |
| Sep 30, 2022 | -147,332.00 |
| Sep 30, 2022 | -147,332.00 |
| Dec 31, 2021 | 674,984.00 |
| Dec 31, 2021 | 674,984.00 |
| Sep 30, 2021 | -2.50 Mn |
| Sep 30, 2021 | -2.50 Mn |